Featured
Among other key figures from pharma and biotech companies, Data2Discovery’s president, David Wild, will be giving a talk on: Boosting Machine Learning with Knowledge Graphs & Node Embeddings. David will be presenting three use cases showing how knowledge graphs that integrate multiple datasets can create new insights and potentially significantly improve efficiency and effectiveness of drug discovery.
Among other key figures from pharma and biotech companies, Data2Discovery’s president, David Wild, will be giving a talk on: Boosting Machine Learning with Knowledge Graphs & Node Embeddings. David will be presenting three use cases showing how knowledge graphs that integrate multiple datasets can create new insights and potentially significantly improve efficiency and effectiveness of drug discovery.
Data2Discovery is a sponsor of the AI Applications Summit: BioPharma in Boston October 25 & 26, 2018. President & Founder Dr David Wild will be speaking on Knowledge Graphs: A transformative new approach for drug discovery.
Derek Marren, Research IT Director at Eli Lilly, will be presenting Discovering Unknown Insights: How We Should Be Recycling Data, Not Just Our Trash in the Pharmaceutical R&D Informatics track at BioIT World this month. Come along to learn how Lilly, the Open PHACTS Foundation, and Data2Discovery have collaboratively created an innovative solution to ingest data from disparate sources to form a rich ecosystem leveraging graph databases in an open source environment.
Data2Discovery presents a unique session at the event titled Reinventing Drug Discovery with AI, led by Data2Discovery's Robin McEntire and Dr. David Wild.
Data2Discovery is based in San Francisco, CA and Bloomington, IN.
Contact us at info@d2discovery.com to find out more.